Figures & data
Figure 1. PRISMA flow chart. PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses. #All excluded reports are available in Table S2. From: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.doi: 10.1136/bmj.n71.
![Figure 1. PRISMA flow chart. PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses. #All excluded reports are available in Table S2. From: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.doi: 10.1136/bmj.n71.](/cms/asset/826c2399-123b-467b-bfc0-f67ed18ee138/ijdt_a_2281261_f0001_c.jpg)
Table 1. List of investigations (n = 35) with included patient images in running manuscripts and supplements.
Table 2. Proportion of depicted patients in the five journals with most randomized patients.